Cite

HARVARD Citation

    Zhou, Q. et al. (2020). CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma. Journal for immunotherapy of cancer. 8 (1), p. . [Online]. 
  
Back to record